Article
Effect of hepar-protecting Wuzhi capsule on pharmacokinetics and dose-effect character of tacrolimus in healthy volunteers.
Biopharmaceutics & drug disposition - 1 Aug 2022
Teng Fei, Wang Wei, Zhang Weiyue, Qu Jinlong, Liu Binguo, Chen Jiani, Liu Shiyi, Li Mingming, Chen Wansheng, Wei Hua
Abstract excerpt
Wuzhi capsule (WZC), a preparation of Fructus Schisandra sphenanthera extract, has been used widely for the treatment of viral and drug-induced hepatitis in China. This study aimed to determine the pharmacokinetic parameters of tacrolimus (TAC) when co-administered with WZC and the dose-effect of WZC on tacrolimus in healthy volunteers. The effect of an increased dosage of WZC (1, 2, 6, and 8 capsules once daily)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
